Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg

NCT01619878 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Uncomplicated Falciparum Malaria

Interventions

DRUG: Artemether-lumefantrine (COA566)

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]